BioMarin Pharmaceuticals
BMRN
BMRN
578 hedge funds and large institutions have $10.1B invested in BioMarin Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 85 funds opening new positions, 243 increasing their positions, 184 reducing their positions, and 81 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.1% more ownership
Funds ownership: 96.12% → 96.22% (+0.1%)
1% less funds holding
Funds holding: 581 → 578 (-3)
21% less capital invested
Capital invested by funds: $12.9B → $10.1B (-$2.73B)
Holders
578
Holding in Top 10
7
Calls
$81.1M
Puts
$73M
Top Buyers
| 1 | +$146M | |
| 2 | +$119M | |
| 3 | +$81.8M | |
| 4 |
Morgan Stanley
New York
|
+$76.2M |
| 5 |
Renaissance Technologies
New York
|
+$50.1M |
Top Sellers
| 1 | -$481M | |
| 2 | -$247M | |
| 3 | -$112M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$110M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$103M |
